Clinical Trials Using Lutetium Lu 177-Edotreotide

Clinical trials are research studies that involve people. The clinical trials on this list are studying Lutetium Lu 177-Edotreotide. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

    The purpose of the study is to evaluate efficacy and safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide compared to targeted molecular therapy with Everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET).
    Location: Moffitt Cancer Center, Tampa, Florida